Indaptus Therapeutics Stock Price History
INDP Stock | USD 0.84 0.03 3.45% |
Below is the normalized historical share price chart for Indaptus Therapeutics extending back to December 26, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Indaptus Therapeutics stands at 0.84, as last reported on the 19th of January, with the highest price reaching 0.89 and the lowest price hitting 0.82 during the day.
If you're considering investing in Indaptus Stock, it is important to understand the factors that can impact its price. Indaptus Therapeutics holds Efficiency (Sharpe) Ratio of -0.11, which attests that the entity had a -0.11% return per unit of risk over the last 3 months. Indaptus Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Indaptus Therapeutics' Standard Deviation of 6.54, risk adjusted performance of (0.04), and Market Risk Adjusted Performance of 0.7965 to validate the risk estimate we provide.
At this time, Indaptus Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 01/19/2025, Common Stock Shares Outstanding is likely to grow to about 10.1 M, while Common Stock is likely to drop slightly above 71.8 K. . As of 01/19/2025, Price Earnings Ratio is likely to drop to -0.91. In addition to that, Price Book Value Ratio is likely to drop to 1.34. Indaptus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of August 2015 | 200 Day MA 1.6975 | 50 Day MA 0.9927 | Beta 1.131 |
Indaptus |
Sharpe Ratio = -0.1099
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | INDP |
Estimated Market Risk
6.41 actual daily | 57 57% of assets are less volatile |
Expected Return
-0.7 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Indaptus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Indaptus Therapeutics by adding Indaptus Therapeutics to a well-diversified portfolio.
Indaptus Therapeutics Stock Price History Chart
There are several ways to analyze Indaptus Stock price data. The simplest method is using a basic Indaptus candlestick price chart, which shows Indaptus Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 22, 2024 | 1.91 |
Lowest Price | December 27, 2024 | 0.84 |
Indaptus Therapeutics January 19, 2025 Stock Price Synopsis
Various analyses of Indaptus Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Indaptus Stock. It can be used to describe the percentage change in the price of Indaptus Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Indaptus Stock.Indaptus Therapeutics Price Action Indicator | (0.03) | |
Indaptus Therapeutics Price Rate Of Daily Change | 0.97 | |
Indaptus Therapeutics Price Daily Balance Of Power | (0.43) |
Indaptus Therapeutics January 19, 2025 Stock Price Analysis
Indaptus Stock Price History Data
The price series of Indaptus Therapeutics for the period between Mon, Oct 21, 2024 and Sun, Jan 19, 2025 has a statistical range of 1.07 with a coefficient of variation of 20.44. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.09. The median price for the last 90 days is 1.03. The company completed 1:4 stock split on 27th of July 2021. Indaptus Therapeutics completed dividends distribution on 2020-10-30.Open | High | Low | Close | Volume | ||
01/19/2025 | 0.82 | 0.89 | 0.82 | 0.84 | ||
01/17/2025 | 0.82 | 0.89 | 0.82 | 0.84 | 7,519 | |
01/16/2025 | 0.89 | 0.89 | 0.83 | 0.84 | 24,359 | |
01/15/2025 | 0.88 | 0.90 | 0.86 | 0.87 | 29,489 | |
01/14/2025 | 0.94 | 0.94 | 0.86 | 0.90 | 12,969 | |
01/13/2025 | 0.96 | 0.96 | 0.89 | 0.95 | 21,695 | |
01/10/2025 | 1.00 | 1.00 | 0.91 | 0.95 | 28,729 | |
01/08/2025 | 1.03 | 1.06 | 0.95 | 0.97 | 54,101 | |
01/07/2025 | 0.98 | 1.03 | 0.95 | 1.01 | 9,030 | |
01/06/2025 | 0.95 | 1.00 | 0.89 | 0.95 | 49,161 | |
01/03/2025 | 0.88 | 0.92 | 0.85 | 0.88 | 18,706 | |
01/02/2025 | 0.82 | 0.92 | 0.82 | 0.85 | 6,475 | |
12/31/2024 | 0.85 | 0.90 | 0.82 | 0.84 | 28,168 | |
12/30/2024 | 0.81 | 0.94 | 0.81 | 0.87 | 29,249 | |
12/27/2024 | 0.86 | 0.89 | 0.82 | 0.84 | 23,306 | |
12/26/2024 | 0.89 | 0.92 | 0.81 | 0.85 | 67,496 | |
12/24/2024 | 0.91 | 0.94 | 0.91 | 0.91 | 4,027 | |
12/23/2024 | 0.91 | 0.94 | 0.88 | 0.89 | 32,565 | |
12/20/2024 | 0.95 | 0.95 | 0.89 | 0.94 | 23,784 | |
12/19/2024 | 0.99 | 1.01 | 0.89 | 0.89 | 11,144 | |
12/18/2024 | 0.90 | 1.00 | 0.90 | 0.91 | 22,515 | |
12/17/2024 | 0.96 | 0.96 | 0.91 | 0.91 | 19,377 | |
12/16/2024 | 1.00 | 1.02 | 0.96 | 0.96 | 44,701 | |
12/13/2024 | 0.99 | 1.02 | 0.99 | 1.00 | 15,486 | |
12/12/2024 | 1.01 | 1.03 | 1.00 | 1.01 | 7,370 | |
12/11/2024 | 0.99 | 1.03 | 0.98 | 0.98 | 12,546 | |
12/10/2024 | 1.00 | 1.01 | 0.98 | 1.00 | 8,509 | |
12/09/2024 | 1.06 | 1.06 | 0.98 | 1.00 | 35,021 | |
12/06/2024 | 1.01 | 1.05 | 0.97 | 1.04 | 28,124 | |
12/05/2024 | 0.96 | 1.00 | 0.94 | 0.96 | 11,542 | |
12/04/2024 | 1.01 | 1.01 | 0.96 | 0.97 | 22,320 | |
12/03/2024 | 0.99 | 1.03 | 0.99 | 1.03 | 13,247 | |
12/02/2024 | 1.08 | 1.10 | 1.00 | 1.00 | 31,805 | |
11/29/2024 | 1.04 | 1.04 | 1.02 | 1.02 | 7,452 | |
11/27/2024 | 1.04 | 1.06 | 1.01 | 1.03 | 45,789 | |
11/26/2024 | 1.06 | 1.06 | 1.01 | 1.04 | 8,051 | |
11/25/2024 | 0.96 | 1.07 | 0.96 | 1.03 | 44,493 | |
11/22/2024 | 1.04 | 1.04 | 0.84 | 1.00 | 102,580 | |
11/21/2024 | 1.05 | 1.06 | 1.02 | 1.05 | 9,063 | |
11/20/2024 | 1.04 | 1.08 | 1.03 | 1.06 | 11,841 | |
11/19/2024 | 1.08 | 1.08 | 1.02 | 1.03 | 41,111 | |
11/18/2024 | 1.16 | 1.20 | 1.10 | 1.10 | 16,575 | |
11/15/2024 | 1.11 | 1.15 | 1.11 | 1.11 | 19,162 | |
11/14/2024 | 1.18 | 1.18 | 1.11 | 1.13 | 14,880 | |
11/13/2024 | 1.15 | 1.20 | 1.15 | 1.18 | 11,330 | |
11/12/2024 | 1.14 | 1.20 | 1.13 | 1.15 | 10,833 | |
11/11/2024 | 1.24 | 1.31 | 1.16 | 1.21 | 29,961 | |
11/08/2024 | 1.26 | 1.31 | 1.14 | 1.19 | 35,674 | |
11/07/2024 | 1.18 | 1.25 | 1.17 | 1.19 | 26,389 | |
11/06/2024 | 1.15 | 1.20 | 1.11 | 1.16 | 24,662 | |
11/05/2024 | 1.17 | 1.19 | 1.14 | 1.15 | 13,109 | |
11/04/2024 | 1.14 | 1.22 | 1.13 | 1.17 | 40,214 | |
11/01/2024 | 1.15 | 1.20 | 1.08 | 1.17 | 93,640 | |
10/31/2024 | 1.25 | 1.25 | 1.13 | 1.17 | 48,617 | |
10/30/2024 | 1.20 | 1.25 | 1.19 | 1.24 | 34,461 | |
10/29/2024 | 1.43 | 1.43 | 1.16 | 1.24 | 124,308 | |
10/28/2024 | 1.33 | 1.54 | 1.23 | 1.54 | 122,654 | |
10/25/2024 | 1.48 | 1.54 | 1.22 | 1.35 | 156,200 | |
10/24/2024 | 1.64 | 1.69 | 1.46 | 1.49 | 198,427 | |
10/23/2024 | 1.75 | 1.78 | 1.44 | 1.69 | 598,898 | |
10/22/2024 | 1.56 | 2.08 | 1.55 | 1.91 | 4,467,175 |
About Indaptus Therapeutics Stock history
Indaptus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Indaptus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Indaptus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Indaptus Therapeutics stock prices may prove useful in developing a viable investing in Indaptus Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 9.7 M | 10.1 M | |
Net Loss | -12.9 M | -12.2 M |
Indaptus Therapeutics Stock Technical Analysis
Indaptus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
All Next | Launch Module |
Indaptus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Indaptus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Indaptus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Indaptus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.37) | |||
Total Risk Alpha | (0.54) | |||
Treynor Ratio | 0.7865 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.